Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
14.37%
operating margin TTM
17.01%
revenue TTM
3.56 Billion
revenue per share TTM
15.58$
valuation ratios | |
|---|---|
| pe ratio | 51.10 |
| peg ratio | 0.51 |
| price to book ratio | 5.25 |
| price to sales ratio | 7.33 |
| enterprise value multiple | 23.68 |
| price fair value | 5.25 |
profitability ratios | |
|---|---|
| gross profit margin | 74.64% |
| operating profit margin | 17.01% |
| pretax profit margin | 14.52% |
| net profit margin | 14.37% |
| return on assets | 5.72% |
| return on equity | 10.7% |
| return on capital employed | 7.56% |
liquidity ratios | |
|---|---|
| current ratio | 3.85 |
| quick ratio | 3.67 |
| cash ratio | 2.48 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 67.26 |
| operating cycle | 135.28 |
| days of payables outstanding | 61.80 |
| cash conversion cycle | 73.48 |
| receivables turnover | 5.37 |
| payables turnover | 5.91 |
| inventory turnover | 5.43 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.28 |
| debt equity ratio | 0.51 |
| long term debt to capitalization | 0.33 |
| total debt to capitalization | 0.34 |
| interest coverage | 7.38 |
| cash flow to debt ratio | 0.49 |
cash flow ratios | |
|---|---|
| free cash flow per share | 4.94 |
| cash per share | 10.39 |
| operating cash flow per share | 5.49 |
| free cash flow operating cash flow ratio | 0.90 |
| cash flow coverage ratios | 0.49 |
| short term coverage ratios | 78.62 |
| capital expenditure coverage ratio | 9.96 |
Frequently Asked Questions
When was the last time Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) reported earnings?
Horizon Therapeutics Public Limited Company (HZNP) published its most recent earnings results on 08-08-2023.
What is Horizon Therapeutics Public Limited Company's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)'s trailing twelve months ROE is 10.7%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Horizon Therapeutics Public Limited Company (HZNP) currently has a ROA of 5.72%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HZNP's net profit margin stand at?
HZNP reported a profit margin of 14.37% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HZNP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.85 in the most recent quarter. The quick ratio stood at 3.67, with a Debt/Eq ratio of 0.51.